Mast Cells in Connective Tissue Regulation and Altered Regulation in Hypermobility Ehlers-Danlos Syndrome (hEDS): Why the Association of Mast Cell Activation Syndrome and hEDS? — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Mast Cells in Connective Tissue Regulation and Altered Regulation in Hypermobility Ehlers-Danlos Syndrome (hEDS): Why the Association of Mast Cell Activation Syndrome and hEDS?
Department of Surgery, Faculty of Kinesiology and McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, Alberta, Canada
1 Department of Surgery, Faculty of Kinesiology and McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, Alberta, Canada
Mast cells (MC) arose early during the evolution of the immune system. While these cells are very involved in host defense against a variety of organisms, they are also found associated with many connective tissues of the musculoskeletal system. As MC contain granules with many potent biologically active mediators and can also synthesize others, their presence in connective tissues could pose a risk for compromise of connective tissue integrity. Despite such risk, the presence of MC in these tissues may imply that they also serve functions related to tissue homeostasis, repair and adaptation, and are capable of functioning in a variety of biomechanically active environments. Their dysregulation, such as in Mast Cell Activation Syndromes (MCAS) could contribute to conditions associated with loss of connective tissue integrity. Interestingly, MCAS has also been reported to be associated with subsets of patients with hypermobility Ehlers-Danlos syndromes (hEDS). This perspective article discusses the potential roles of MC in normal connective tissue states and then discusses aspects of the relationship between MC and hEDS. It is concluded that there is a need to better understand the role of MC in this context, and how the study of the involvement of MCAS and EDS presents a model to examine these relationships in detail.
Bacci, S. (2026) The Evolution of Mast Cells across All Vertebrate Classes: The Mystery Continues. Histology and Histopathology , 41, 1-9.
Greene, D., Moore Fried, J. and Wang, J. (2025) IgE in Allergic Diseases. Immunological Reviews , 334, e70057. https://doi.org/10.1111/imr.70057
Elst, J., Ebo, D.G. and Sabato, V. (2025) Human Mast Cells in Anaphylaxis: From Research to Diagnosis. Current Opinion in Allergy & Clinical Immunology , 25, 315-321. https://doi.org/10.1097/aci.0000000000001092
Sobiepanek, A., Kuryk, Ł., Garofalo, M., Kumar, S., Baran, J., Musolf, P., et al. (2022) The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers. International Journal of Molecular Sciences , 23, Article No. 2249. https://doi.org/10.3390/ijms23042249
Żelechowska, P. and Góralczyk-Bińkowska, A. (2025) Mast Cell Response to Parasites: From Recognition and Activation to Host Defense Modulation. Cellular Physiology and Biochemistry , 59, 631-651. https://doi.org/10.33594/000000815
Biswas, R., Fried, J.M. and Curotto de Lafaille, M.A. (2026) Expanding the Immunologic and Neuronal Landscape of IgE-Mediated Anaphylaxis. Immunological Reviews , 337, e70078. https://doi.org/10.1111/imr.70078
Reza, M.I. and Ambhore, N.S. (2025) Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers. Biomedicines , 13, Article No. 1342. https://doi.org/10.3390/biomedicines13061342
Gutowski, Ł., Kanikowski, S. and Formanowicz, D. (2023) Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases. Life , 13, Article No. 1690. https://doi.org/10.3390/life13081690
Hart, D.A., Frank, C.B. and Bray, R. (1995) Inflammatory Processes in Repetitive Motion and Over-Use Syndromes: Potential Role of Neurogenic Mechanisms in Tendons and Ligaments. In: Gordon, S.L., Blair, S.J. and Fine, L.J., Eds., Repetitive Motion Disorders of the Upper Extremity , AAOS, 247-262.
Shaw, H.M., Santer, R.M., Watson, A.H.D. and Benjamin, M. (2007) Adipose Tissue at Entheses: The Innervation and Cell Composition of the Retromalleolar Fat Pad Associated with the Rat Achilles Tendon. Journal of Anatomy , 211, 436-443. https://doi.org/10.1111/j.1469-7580.2007.00791.x
Damsgaard, T.E., Sørensen, F.B., Herlin, T. and Schiøtz, P.O. (1999) Stereological Quantification of Mast Cells in Human Synovium. APMIS , 107, 311-317. https://doi.org/10.1111/j.1699-0463.1999.tb01559.x
Kashiwakura, J., Yanagisawa, M., Lee, H., Okamura, Y., Sasaki-Sakamoto, T., Saito, S., et al. (2013) Interleukin-33 Synergistically Enhances Immune Complex-Induced Tumor Necrosis Factor Alpha and Interleukin-8 Production in Cultured Human Synovium-Derived Mast Cells. International Archives of Allergy and Immunology , 161, 32-36. https://doi.org/10.1159/000350424
Hildebrand, K.A. (2013) Posttraumatic Elbow Joint Contractures: Defining Pathologic Capsular Mechanisms and Potential Future Treatment Paradigms. The Journal of Hand Surgery , 38, 2227-2233. https://doi.org/10.1016/j.jhsa.2013.07.031
Li, D., Han, Y., Zhou, J., Yang, H., Chen, J., Tey, H.L., et al. (2025) Mast Cell-Neuron Axis as a Core Mechanism in Chronic Pruritus of Atopic Dermatitis: From Mechanistic Insights to Therapeutic Targets. Frontiers in Immunology , 16, Article ID: 1645095. https://doi.org/10.3389/fimmu.2025.1645095
A, S., Ulzii, D., Yadamsuren, E. and Shi, J. (2025) Functional Heterogeneity of Mast Cells in Cutaneous Inflammation: Implications for Precision Medicine. Frontiers in Immunology , 16, Article ID: 1680574. https://doi.org/10.3389/fimmu.2025.1680574
Ishii, K., Nagata, K., Yamashita, N., Yamazaki, Y., Akimoto, Y., Zhao, W., et al. (2025) PU.1 and TGF-B Signaling Activate the Cell-Surface Expression of CD103 in Mast Cells and Dendritic Cells: Opposite Roles of GATA2 in Expression of Mucosal Mast Cell Genes. The FEBS Journal , 292, 6117-6133. https://doi.org/10.1111/febs.70252
Galván-Morales, M.Á., Vizuet-de-Rueda, J.C., Montero-Vargas, J.M. and Teran, L.M. (2025) Role of Mast Cells in Human Health and Disease: Controversies and Novel Therapies. International Journal of Molecular Sciences , 26, Article No. 8895. https://doi.org/10.3390/ijms26188895
Xu, H., Shi, X., Li, X., Zou, J., Zhou, C., Liu, W., et al. (2020) Neurotransmitter and Neuropeptide Regulation of Mast Cell Function: A Systematic Review. Journal of Neuroinflammation , 17, Article No. 356. https://doi.org/10.1186/s12974-020-02029-3
Lauritano, D., Mastrangelo, F., D’Ovidio, C., Ronconi, G., Caraffa, A., Gallenga, C.E., et al. (2023) Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines. International Journal of Molecular Sciences , 24, Article No. 4811. https://doi.org/10.3390/ijms24054811
Wilgus, T.A., Ud-Din, S. and Bayat, A. (2020) A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis. International Journal of Molecular Sciences , 21, Article No. 9673. https://doi.org/10.3390/ijms21249673
Douaiher, J., Succar, J., Lancerotto, L., Gurish, M.F., Orgill, D.P., Hamilton, M.J., et al. (2014) Development of Mast Cells and Importance of Their Tryptase and Chymase Serine Proteases in Inflammation and Wound Healing. In: Advances in Immunology , Elsevier, 211-252. https://doi.org/10.1016/b978-0-12-800267-4.00006-7
Wulff, B.C. and Wilgus, T.A. (2013) Mast Cell Activity in the Healing Wound: More than Meets the Eye? Experimental Dermatology , 22, 507-510. https://doi.org/10.1111/exd.12169
Gallant-Behm, C.L., Hildebrand, K.A. and Hart, D.A. (2008) The Mast Cell Stabilizer Ketotifen Prevents Development of Excessive Skin Wound Contraction and Fibrosis in Red Duroc Pigs. Wound Repair and Regeneration , 16, 226-233. https://doi.org/10.1111/j.1524-475x.2008.00363.x
Knowles, A. and Glass, D.A. (2023) Keloids and Hypertrophic Scars. Dermatologic Clinics , 41, 509-517. https://doi.org/10.1016/j.det.2023.02.010
Studdiford, J., Stonehouse, A., Altshuler, M. and Rinzler, E. (2008) The Management of Keloids: Hands-On versus Hands-Off. The Journal of the American Board of Family Medicine , 21, 149-152. https://doi.org/10.3122/jabfm.2008.02.070011
Shih, B., Garside, E., McGrouther, D.A. and Bayat, A. (2010) Molecular Dissection of Abnormal Wound Healing Processes Resulting in Keloid Disease. Wound Repair and Regeneration , 18, 139-153. https://doi.org/10.1111/j.1524-475x.2009.00553.x
Cohen, A.J., Nikbakht, N. and Uitto, J. (2023) Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin. Cold Spring Harbor Perspectives in Biology , 15, a041245. https://doi.org/10.1101/cshperspect.a041245
Sharma, A.N., Birda, A., Park, M., Choe, S., Salas, J., Kincaid, C., et al. (2025) Insights into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study. Journal of Drugs in Dermatology , 24, 212-215. https://doi.org/10.36849/jdd.8401
Nakajima, Y., Aramaki, N., Takeuchi, N., Yamanishi, A., Kumagai, Y., Okabe, K., et al. (2022) Mast Cells Are Activated in the Giant Earlobe Keloids: A Case Series. International Journal of Molecular Sciences , 23, Article No. 10410. https://doi.org/10.3390/ijms231810410
Tang, Y., Ren, K., Yin, X., Yang, Y., Fang, F., Zhou, B., et al. (2023) Tissue RNA Sequencing Reveals Novel Biomarkers Associated with Postoperative Keloid Recurrence. Journal of Clinical Medicine , 12, Article No. 5511. https://doi.org/10.3390/jcm12175511
Zhang, X., Wu, X. and Li, D. (2023) The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy. International Journal of Molecular Sciences , 24, Article No. 15475. https://doi.org/10.3390/ijms242015475
Gong, H., Liu, J., Chen, N., Zhao, H., He, B., Zhang, H., et al. (2025) EDN1 and NTF3 in Keloid Pathogenesis: Computational and Experimental Evidence as Novel Diagnostic Biomarkers for Fibrosis and Inflammation. Frontiers in Genetics , 16, Article ID: 1516451. https://doi.org/10.3389/fgene.2025.1516451
Xu, H., Li, K., Liang, X., Wang, Z. and Yang, B. (2025) Multi-Omics Analysis to Explore the Molecular Mechanisms Related to Keloid. Burns , 51, Article ID: 107396. https://doi.org/10.1016/j.burns.2025.107396
Yeo, E., Shim, J., Oh, S.J., Choi, Y., Noh, H., Kim, H., et al. (2024) Revisiting Roles of Mast Cells and Neural Cells in Keloid: Exploring Their Connection to Disease Activity. Frontiers in Immunology , 15, Article ID: 1339336. https://doi.org/10.3389/fimmu.2024.1339336
Flick, T.R., Wang, C.X., Patel, A.H., Hodo, T.W., Sherman, W.F. and Sanchez, F.L. (2021) Arthrofibrosis after Total Knee Arthroplasty: Patients with Keloids at Risk. Journal of Orthopaedics and Traumatology , 22, Article No. 1. https://doi.org/10.1186/s10195-020-00563-7
Akimoto, S., Ishikawa, O., Iijima, C. and Miyachi, Y. (1999) Expression of Basic Fibroblast Growth Factor and Its Receptor by Fibroblast, Macrophages and Mast Cells in Hypertrophic Scar. European Journal of Dermatology , 9, 357-362.
Wang, J.-F., Ding, J., Jiao, H., Honardoust, D., Momtazi, M., Shankowsky, H.A. and Tredget, E.E. (2011) Human Hypertrophic Scar-Like Nude Mouse Model: Characterization of the Molecular and Cellular Biology of the Scar Process. Wound Repair and Regeneration , 19, 274-285. https://doi.org/10.1111/j.1524-475X.2011.00672.x
Kidzeru, E.B., Lebeko, M., Sharma, J.R., Nkengazong, L., Adeola, H.A., Ndlovu, H., et al. (2023) Immune Cells and Associated Molecular Markers in Dermal Fibrosis with Focus on Raised Cutaneous Scars. Experimental Dermatology , 32, 570-587. https://doi.org/10.1111/exd.14734
Yu, B., Cao, Y., Li, S., Bai, R., Zhou, G., Fu, Q., et al. (2024) Identification and Validation of CRLF1 and NRG1 as Immune-Related Signatures in Hypertrophic Scar. Genomics , 116, Article ID: 110797. https://doi.org/10.1016/j.ygeno.2024.110797
Won, P., Stoycos, S.A., Ding, L., McMullen, K.A., Kowalske, K., Stewart, B.T., et al. (2023) Worse Itch and Fatigue in Racial and Ethnic Minorities: A Burn Model System Study. Journal of Burn Care & Research , 44, 1445-1451. https://doi.org/10.1093/jbcr/irad054
Scott, J.R., Muangman, P. and Gibran, N.S. (2007) Making Sense of Hypertrophic Scar: A Role for Nerves. Wound Repair and Regeneration , 15, S27-S31. https://doi.org/10.1111/j.1524-475x.2007.00222.x
De Henau, M., Schins, S., Colla, C., van den Kerckhove, E., van der Hulst, R. and Tuinder, S. (2025) Are Symptoms in Pathologic Scars Related to Nerve Function or Density? A Scoping Review. Burns , 51, Article ID: 107280. https://doi.org/10.1016/j.burns.2024.10.001
Gallant, C.L., Olson, M.E. and Hart, D.A. (2004) Molecular, Histologic, and Gross Phenotype of Skin Wound Healing in Red Duroc Pigs Reveals an Abnormal Healing Phenotype of Hypercontracted, Hyperpigmented Scarring. Wound Repair and Regeneration , 12, 305-319. https://doi.org/10.1111/j.1067-1927.2004.012311.x
Gallant-Behm, C.L., Tsao, H., Reno, C., Olson, M.E. and Hart, D.A. (2006) Skin Wound Healing in the First Generation (F1) Offspring of Yorkshire and Red Duroc Pigs: Evidence for Genetic Inheritance of Wound Phenotype. Burns , 32, 180-193. https://doi.org/10.1016/j.burns.2005.10.012
Gallant-Behm, C.L. and Hart, D.A. (2006) Genetic Analysis of Skin Wound Healing and Scarring in a Porcine Model. Wound Repair and Regeneration , 14, 46-54. https://doi.org/10.1111/j.1524-475x.2005.00087.x
Gallant-Behm, C.L., Reno, C., Tsao, H. and Hart, D.A. (2007) Genetic Involvement in Skin Wound Healing and Scarring in Domestic Pigs: Assessment of Molecular Expression Patterns in (Yorkshire × Red Duroc) × Yorkshire Backcross Animals. Journal of Investigative Dermatology , 127, 233-244. https://doi.org/10.1038/sj.jid.5700482
Wong, J.W., Gallant-Behm, C., Wiebe, C., Mak, K., Hart, D.A., Larjava, H., et al. (2009) Wound Healing in Oral Mucosa Results in Reduced Scar Formation as Compared with Skin: Evidence from the Red Duroc Pig Model and Humans. Wound Repair and Regeneration , 17, 717-729. https://doi.org/10.1111/j.1524-475x.2009.00531.x
Mak, K., Manji, A., Gallant-Behm, C., Wiebe, C., Hart, D.A., Larjava, H., et al. (2009) Scarless Healing of Oral Mucosa Is Characterized by Faster Resolution of Inflammation and Control of Myofibroblast Action Compared to Skin Wounds in the Red Duroc Pig Model. Journal of Dermatological Science , 56, 168-180. https://doi.org/10.1016/j.jdermsci.2009.09.005
Germscheid, N.M., Thornton, G.M., Hart, D.A. and Hildebrand, K.A. (2012) Wound Healing Differences between Yorkshire and Red Duroc Porcine Medial Collateral Ligaments Identified by Biomechanical Assessment of Scars. Clinical Biomechanics , 27, 91-98. https://doi.org/10.1016/j.clinbiomech.2011.07.001
De Hemptinne, I., Gallant-Behm, C.L., Noack, C.L., Parreno, J. and Hart, D.A. (2008) Dermal Fibroblasts from Red Duroc and Yorkshire Pigs Exhibit Intrinsic Differences in the Contraction of Collagen Gels. Wound Repair and Regeneration , 16, 132-142. https://doi.org/10.1111/j.1524-475x.2007.00340.x
Monument, M.J., Hart, D.A., Salo, P.T., Hildebrand, K.A. and Dean Befus, A. (2013) Posttraumatic Elbow Contractures: Targeting Neuroinflammatory Fibrogenic Mechanisms. Journal of Orthopaedic Science , 18, 869-877. https://doi.org/10.1007/s00776-013-0447-5
Monument, M.J., Hart, D.A., Salo, P.T., Befus, A.D. and Hildebrand, K.A. (2015) Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions. Advances in Wound Care , 4, 137-151. https://doi.org/10.1089/wound.2013.0509
Alim, M.A., Ackermann, P.W., Eliasson, P., Blomgran, P., Kristiansson, P., Pejler, G., et al. (2017) Increased Mast Cell Degranulation and Co-Localization of Mast Cells with the NMDA Receptor-1 during Healing after Achilles Tendon Rupture. Cell and Tissue Research , 370, 451-460. https://doi.org/10.1007/s00441-017-2684-y
Behzad, H., Sharma, A., Mousavizadeh, R., Lu, A. and Scott, A. (2013) Mast Cells Exert Pro-Inflammatory Effects of Relevance to the Pathophyisology of Tendinopathy. Arthritis Research & Therapy , 15, R184. https://doi.org/10.1186/ar4374
Dean, B.J.F., Gettings, P., Dakin, S.G. and Carr, A.J. (2016) Are Inflammatory Cells Increased in Painful Human Tendinopathy? A Systematic Review. British Journal of Sports Medicine , 50, 216-220.
Chisari, E., Rehak, L., Khan, W.S. and Maffulli, N. (2020) The Role of the Immune System in Tendon Healing: A Systematic Review. British Medical Bulletin , 133, 49-64. https://doi.org/10.1093/bmb/ldz040
Scott, A., Lian, Ø., Bahr, R., Hart, D.A., Duronio, V. and Khan, K.M. (2008) Increased Mast Cell Numbers in Human Patellar Tendinosis: Correlation with Symptom Duration and Vascular Hyperplasia. British Journal of Sports Medicine , 42, 753-757. https://doi.org/10.1136/bjsm.2007.040212
Nakano, T., Kurimoto, S., Ishii, H., Iwatsuki, K., Yamamoto, M., Tatebe, M., et al. (2022) Mast Cell Presence in Tendon Sheaths of Trigger Fingers: Implications on Pathogenesis and Clinical Presentation. Journal of Plastic Surgery and Hand Surgery , 57, 257-262. https://doi.org/10.1080/2000656x.2022.2061498
Pingel, J., Wienecke, J., Kongsgaard, M., Behzad, H., Abraham, T., Langberg, H., et al. (2013) Increased Mast Cell Numbers in a Calcaneal Tendon Overuse Model. Scandinavian Journal of Medicine & Science in Sports , 23, e353-e360. https://doi.org/10.1111/sms.12089
Berglund, M.E., Hildebrand, K.A., Zhang, M., Hart, D.A. and Wiig, M.E. (2010) Neuropeptide, Mast Cell, and Myofibroblast Expression after Rabbit Deep Flexor Tendon Repair. The Journal of Hand Surgery , 35, 1842-1849. https://doi.org/10.1016/j.jhsa.2010.06.031
Kulka, M., Sheen, C.H., Tancowny, B.P., Grammer, L.C. and Schleimer, R.P. (2008) Neuropeptides Activate Human Mast Cell Degranulation and Chemokine Production. Immunology , 123, 398-410. https://doi.org/10.1111/j.1365-2567.2007.02705.x
Aitella, E., Romano, C., Ginaldi, L. and Cozzolino, D. (2025) Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation. International Journal of Molecular Sciences , 26, Article No. 927. https://doi.org/10.3390/ijms26030927
Scott, A. and Bahr, R. (2009) Neuropeptides in Tendinopathy. Frontiers in Bioscience , 14, 2203-2211. https://doi.org/10.2741/3372
Ackermann, P.W., Salo, P.T. and Hart, D.A. (2009) Neuronal Pathways in Tendon Healing. Frontiers in Bioscience , 14, 5165-5187. https://doi.org/10.2741/3593
Ackermann, P.W., et al. (2014) Neuronal Pathways in Tendon Healing and Tendinopathy—Update. Frontiers in Bioscience , 19, 1251-1278. https://doi.org/10.2741/4280
Bring, D.K., Paulson, K., Renstrom, P., Salo, P., Hart, D.A. and Ackermann, P.W. (2012) Residual Substance p Levels after Capsaicin Treatment Correlate with Tendon Repair. Wound Repair and Regeneration , 20, 50-60. https://doi.org/10.1111/j.1524-475x.2011.00755.x
Alim, M.A., Peterson, M. and Pejler, G. (2020) Do Mast Cells Have a Role in Tendon Healing and Inflammation? Cells , 9, Article No. 1134. https://doi.org/10.3390/cells9051134
Bring, D.K.-., Reno, C., Renstrom, P., Salo, P., Hart, D.A. and Ackermann, P.W. (2008) Joint Immobilization Reduces the Expression of Sensory Neuropeptide Receptors and Impairs Healing after Tendon Rupture in a Rat Model. Journal of Orthopaedic Research , 27, 274-280. https://doi.org/10.1002/jor.20657
Gao, R., Ye, T., Zhu, Z., Li, Q., Zhang, J., Yuan, J., et al. (2022) Small Extracellular Vesicles from iPSC-Derived Mesenchymal Stem Cells Ameliorate Tendinopathy Pain by Inhibiting Mast Cell Activation. Nanomedicine , 17, 513-529. https://doi.org/10.2217/nnm-2022-0036
Sharma, A., Abraham, T., Sampaio, A., Cowan, M., Underhill, M. and Scott, A. (2011) Sodium Cromolyn Reduces Expression of CTGF, ADAMTS1, and TIMP3 and Modulates Post-Injury Patellar Tendon Morphology. Journal of Orthopaedic Research , 29, 678-683. https://doi.org/10.1002/jor.21291
Oh, S.Y., Kim, D.K., Han, S.H., Lee, H.H., Jeong, Y., Baek, M., et al. (2020) Sustained Exposure of Substance P Causes Tendinopathy. International Journal of Molecular Sciences , 21, Article No. 8633. https://doi.org/10.3390/ijms21228633
Zhou, Y., Zhou, B. and Tang, K. (2015) The Effects of Substance P on Tendinopathy Are Dose-Dependent: An in Vitro and in Vivo Model Study. The Journal of nutrition , health and aging , 19, 555-561. https://doi.org/10.1007/s12603-014-0576-3
Hildebrand, K.A., Schneider, P.S., Mohtadi, N.G.H., Ademola, A., White, N.J., Garven, A., et al. (2020) Prevention of Posttraumatic Contractures with Ketotifen 1 (PERK 1): A Randomized Clinical Trial. Journal of Orthopaedic Trauma , 34, e442-e448. https://doi.org/10.1097/bot.0000000000001878
Ademola, A., Hildebrand, K.A., Schneider, P.S., Mohtadi, N.G.H., White, N.J., Bosse, M.J., et al. (2020) Prevention of Posttraumatic Contractures with Ketotifen 2 (PERK 2)—Protocol for a Multicenter Randomized Clinical Trial. BMC Musculoskeletal Disorders , 21, Article No. 123. https://doi.org/10.1186/s12891-020-3139-2
Hildebrand, K.A., Zhang, M., van Snellenberg, W., King, G.J.W. and Hart, D.A. (2004) Myofibroblast Numbers Are Elevated in Human Elbow Capsules after Trauma. Clinical Orthopaedics and Related Research , 419, 189-197. https://doi.org/10.1097/00003086-200402000-00031
Hildebrand, K.A., Zhang, M. and Hart, D.A. (2007) Myofibroblast Upregulators Are Elevated in Joint Capsules in Posttraumatic Contractures. Clinical Orthopaedics & Related Research , 456, 85-91. https://doi.org/10.1097/blo.0b013e3180312c01
Hildebrand, K.A., Zhang, M. and Hart, D.A. (2008) Joint Capsule Mast Cells and Neuropeptides Are Increased within Four Weeks of Injury and Remain Elevated in Chronic Stages of Posttraumatic Contractures. Journal of Orthopaedic Research , 26, 1313-1319. https://doi.org/10.1002/jor.20652
Hildebrand, K.A., Zhang, M., Germscheid, N.M., Wang, C. and Hart, D.A. (2008) Cellular, Matrix, and Growth Factor Components of the Joint Capsule Are Modified Early in the Process of Posttraumatic Contracture Formation in a Rabbit Model. Acta Orthopaedica , 79, 116-125. https://doi.org/10.1080/17453670710014860
Liu, C.S., Ademola, A., Zhang, M., Garven, A., Kopka, M., Salo, P.T., et al. (2020) Human Serum Mast Cell Tryptase Levels in Elbow Fractures or Dislocations and Its Association with Injury Severity. Journal of Orthopaedic Research , 38, 2015-2019. https://doi.org/10.1002/jor.24642
Hildebrand, K.A., Zhang, M., Befus, A.D., Salo, P.T. and Hart, D.A. (2014) A Myofibroblast-Mast Cell-Neuropeptide Axis of Fibrosis in Post-Traumatic Joint Contractures: An in Vitro Analysis of Mechanistic Components. Journal of Orthopaedic Research , 32, 1290-1296. https://doi.org/10.1002/jor.22676
Hildebrand, K.A., Zhang, M. and Hart, D.A. (2006) Joint Capsule Matrix Turnover in a Rabbit Model of Chronic Joint Contractures: Correlation with Human Contractures. Journal of Orthopaedic Research , 24, 1036-1043. https://doi.org/10.1002/jor.20128
Kopka, M., Monument, M.J., Befus, A.D., Zhang, M., Hart, D.A., Salo, P.T., et al. (2017) Serum Mast Cell Tryptase as a Marker of Posttraumatic Joint Contracture in a Rabbit Model. Journal of Orthopaedic Trauma , 31, e86-e89. https://doi.org/10.1097/bot.0000000000000747
Monument, M.J., Hart, D.A., Befus, A.D., Salo, P.T., Zhang, M. and Hildebrand, K.A. (2010) The Mast Cell Stabilizer Ketotifen Fumarate Lessens Contracture Severity and Myofibroblast Hyperplasia: A Study of a Rabbit Model of Posttraumatic Joint Contractures. The Journal of Bone and Joint Surgery - American Volume , 92, 1468-1477. https://doi.org/10.2106/jbjs.i.00684
Monument, M.J., Hart, D.A., Befus, A.D., Salo, P.T., Zhang, M. and Hildebrand, K.A. (2012) The Mast Cell Stabilizer Ketotifen Reduces Joint Capsule Fibrosis in a Rabbit Model of Post-Traumatic Joint Contractures. Inflammation Research , 61, 285-292. https://doi.org/10.1007/s00011-011-0409-3
Schneider, P.S., Johal, H., Befus, A.D., Salo, P.T., Hart, D.A. and Hildebrand, K.A. (2021) The Dose-Response Effect of the Mast Cell Stabilizer Ketotifen Fumarate on Posttraumatic Joint Contracture: An in Vivo Study in a Rabbit Model. JBJS Open Access , 6, e20.00057. https://doi.org/10.2106/jbjs.oa.20.00057
Hart, D.A. (2026) Potential Role of Mast Cells in Intervertebral Disc Ageing, Herniation Resolution, and Degeneration: Evidence and Lessons Learned from Studies of Mast Cells in Other Connective Tissues. International Journal of Molecular Sciences , 27, Article No. 2804. https://doi.org/10.3390/ijms27062804
Wiet, M.G., Piscioneri, A., Khan, S.N., Ballinger, M.N., Hoyland, J.A. and Purmessur, D. (2017) Mast Cell-Intervertebral Disc Cell Interactions Regulate Inflammation, Catabolism and Angiogenesis in Discogenic Back Pain. Scientific Reports , 7, Article No. 12492. https://doi.org/10.1038/s41598-017-12666-z
Oegema, T.R. (2002) The Role of Disc Cell Heterogeneity in Determining Disc Biochemistry: A Speculation. Biochemical Society Transactions , 30, 839-844. https://doi.org/10.1042/bst0300839
Hunter, C.J., Matyas, J.R. and Duncan, N.A. (2003) The Notochordal Cell in the Nucleus Pulposus: A Review in the Context of Tissue Engineering. Tissue Engineering , 9, 667-677. https://doi.org/10.1089/107632703768247368
de Vries, M.H.E., Caelers, I.J.M.H., van Hemert, W.L.W., Boselie, T.F.M. and van Santbrink, H. (2025) Physiological Ageing of the Lumbar Intervertebral Disc Based on Magnetic Resonance Imaging, a Systematic Literature Review. Medicina , 61, Article No. 1430. https://doi.org/10.3390/medicina61081430
Peng, B., Hao, J., Hou, S., Wu, W., Jiang, D., Fu, X., et al. (2006) Possible Pathogenesis of Painful Intervertebral Disc Degeneration. Spine , 31, 560-566. https://doi.org/10.1097/01.brs.0000201324.45537.46
Staszkiewicz, R., Gładysz, D., Gralewski, M., Garczarek, M., Gadzieliński, M. and Grabarek, B.O. (2023) Pathomechanism of the IVDs Degeneration and the Role of Neurotrophic Factors and Concentration of Selected Elements in Genesis of Low Back Pain. Current Pharmaceutical Biotechnology , 24, 1164-1177. https://doi.org/10.2174/1389201024666221021142904
He, S., Liu, X., Luo, S., Li, H., Min, J. and Shi, Q. (2024) Mast Cells and Their Related Gene HK-1 Are Closely Associated with Discogenic Low Back Pain: A Bioinformatics and Clinical Sample Study. Journal of Pain Research , 17, 1401-1412. https://doi.org/10.2147/jpr.s454785
Komi, D.E.A., Khomtchouk, K. and Santa Maria, P.L. (2020) A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms. Clinical Reviews in Allergy & Immunology , 58, 298-312. https://doi.org/10.1007/s12016-019-08729-w
Awad-Igbaria, Y., Edelman, D., Ianshin, E., Abu-Ata, S., Shamir, A., Bornstein, J., et al. (2025) Inflammation-induced Mast Cell-Derived Nerve Growth Factor: A Key Player in Chronic Vulvar Pain? Brain , 148, 331-346. https://doi.org/10.1093/brain/awae228
Groneberg, D.A., Fischer, T.C., Peckenschneider, N., Noga, O., Dinh, Q.T., Welte, T., et al. (2007) Cell Type-specific Regulation of Brain-derived Neurotrophic Factor in States of Allergic Inflammation. Clinical & Experimental Allergy , 37, 1386-1391. https://doi.org/10.1111/j.1365-2222.2007.02790.x
Frost, L.R., Bijman, M., Strzalkowski, N.D.J., Bent, L.R. and Brown, S.H.M. (2015) Deficits in Foot Skin Sensation Are Related to Alterations in Balance Control in Chronic Low Back Patients Experiencing Clinical Signs of Lumbar Nerve Root Impingement. Gait & Posture , 41, 923-928. https://doi.org/10.1016/j.gaitpost.2015.03.345
Dumont, N., Lepage, K., Côté, C.H. and Frenette, J. (2007) Mast Cells Can Modulate Leukocyte Accumulation and Skeletal Muscle Function Following Hindlimb Unloading. Journal of Applied Physiology , 103, 97-104. https://doi.org/10.1152/japplphysiol.01132.2006
Fowlkes, V., Wilson, C.G., Carver, W. and Goldsmith, E.C. (2013) Mechanical Loading Promotes Mast Cell Degranulation via RGD-Integrin Dependent Pathways. Journal of Biomechanics , 46, 788-795. https://doi.org/10.1016/j.jbiomech.2012.11.014
Geiss, A., Larsson, K., Rydevik, B., Takahashi, I. and Olmarker, K. (2007) Autoimmune Properties of Nucleus Pulposus: An Experimental Study in Pigs. Spine , 32, 168-173. https://doi.org/10.1097/01.brs.0000251651.61844.2d
Petra, A.I., Panagiotidou, S., Stewart, J.M., Conti, P. and Theoharides, T.C. (2014) Spectrum of Mast Cell Activation Disorders. Expert Review of Clinical Immunology , 10, 729-739. https://doi.org/10.1586/1744666x.2014.906302
Hormet Igde, M., Korkmaz, P., Toprak, I.D., Eyice Karabacak, D., Demir, S., Unal, D., et al. (2025) Idiopathic Mast Cell Activation Syndrome in Real-Life Practice: Clinical Features and Management. Allergy and Asthma Proceedings , 46, 314-322. https://doi.org/10.2500/aap.2025.46.250025
Akin, C., Butterfield, J.H., Castells, M. and Lyons, J.J. (2025) Management of Indolent Mastocytosis and Mast Cell Activation Syndrome: A Clinical Yardstick. Annals of Allergy , Asthma & Immunology , 135, 466-477. https://doi.org/10.1016/j.anai.2025.06.032
Akin, C., Gülen, T., Castells, M.C., Elberink, H.O. and Valent, P. (2026) Diagnosis and Management of Patients with Mast Cell Activation Syndromes: Status 2026. The Journal of Allergy and Clinical Immunology : In Practice , 14, 19-28. https://doi.org/10.1016/j.jaip.2025.10.046
Quinn, A.M. (2023) Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome and Associated Conditions: A Case Report. Integrative Medicine ( Encinitas ), 22, 36-41.
Gulen, T. (2024) Using the Right Criteria for MCAS. Current Allergy and Asthma Reports , 24, 39-51. https://doi.org/10.1007/s11882-024-01126-0
Gülen, T. and Akin, C. (2025) How We Treat Mast Cell Activation Syndrome. Annals of Allergy , Asthma & Immunology , 135, 33-36. https://doi.org/10.1016/j.anai.2025.01.017
Hamilton, M.J. (2018) Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunology and Allergy Clinics of North America , 38, 469-481. https://doi.org/10.1016/j.iac.2018.04.002
Royer, S.P. and Han, S.J. (2022) Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome. Frontiers in Cell and Developmental Biology , 10, Article ID: 874840. https://doi.org/10.3389/fcell.2022.874840
Frieri, M. (2015) Mast Cell Activation Syndrome. Clinical Reviews in Allergy & Immunology , 54, 353-365. https://doi.org/10.1007/s12016-015-8487-6
Zaghmout, T., Maclachlan, L., Bedi, N. and Gülen, T. (2024) Low Prevalence of Idiopathic Mast Cell Activation Syndrome among 703 Patients with Suspected Mast Cell Disorders. The Journal of Allergy and Clinical Immunology : In Practice , 12, 753-761. https://doi.org/10.1016/j.jaip.2023.11.041
Matheny, M.V., Craig, T. and Al-Shaikhly, T. (2025) Systematic Review of Omalizumab for Refractory Clonal and Non-Clonal Mast Cell Activation Syndrome. Allergy and Asthma Proceedings , 46, 11-18. https://doi.org/10.2500/aap.2025.46.240076
Yao, L., Subramaniam, K., Raja, K.M., Arunachalam, A., Tran, A., Pandey, T., et al. (2025) Association of Postural Orthostatic Tachycardia Syndrome, Hypermobility Spectrum Disorders, and Mast Cell Activation Syndrome in Young Patients; Prevalence, Overlap and Response to Therapy Depends on the Definition. Frontiers in Neurology , 16, Article ID: 1513199. https://doi.org/10.3389/fneur.2025.1513199
Farley, M., Estrada-Mendizabal, R.J., Gansert, E.A., Voelker, D., Marks, L.A. and Gonzalez-Estrada, A. (2025) Prevalence of Mast Cell Activation Disorders and Hereditary Alpha Tryptasemia among Patients with Postural Orthostatic Tachycardia Syndrome and Ehlers-Danlos Syndrome: A Systematic Review. Annals of Allergy , Asthma & Immunology , 135, 97-102. https://doi.org/10.1016/j.anai.2025.03.022
Mihele, D., Nistor, P., Bruma, G., Mitran, C., Mitran, M., Condrat, C., et al. (2023) Mast Cell Activation Syndrome Update—A Dermatological Perspective. Journal of Personalized Medicine , 13, Article No. 1116. https://doi.org/10.3390/jpm13071116
Afrin, L.B., Pöhlau, D., Raithel, M., Haenisch, B., Dumoulin, F.L., Homann, J., et al. (2015) Mast Cell Activation Disease: An Underappreciated Cause of Neurologic and Psychiatric Symptoms and Diseases. Brain , Behavior , and Immunity , 50, 314-321. https://doi.org/10.1016/j.bbi.2015.07.002
Butterfield, J.H. and Taylor, A. (2025) Acute/Baseline Ratios of All 3 MC Mediator Metabolites Can Enhance Diagnosis and Management of Mast Cell Activation Syndrome. Journal of Allergy and Clinical Immunology : Global , 4, Article ID: 100399. https://doi.org/10.1016/j.jacig.2024.100399
Beyens, M., Toscano, A., Ebo, D., Gülen, T. and Sabato, V. (2023) Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders. Diagnostics , 13, Article No. 3662. https://doi.org/10.3390/diagnostics13243662
Bell, M.C. and Jackson, D.J. (2012) Prevention of Anaphylaxis Related to Mast Cell Activation Syndrome with Omalizumab. Annals of Allergy , Asthma & Immunology , 108, 383-384. https://doi.org/10.1016/j.anai.2012.02.021
Berry, R., Hollingsworth, P. and Lucas, M. (2019) Successful Treatment of Idiopathic Mast Cell Activation Syndrome with Low-Dose Omalizumab. Clinical & Translational Immunology , 8, e01075. https://doi.org/10.1002/cti2.1075
Jagdis, A. and Vadas, P. (2014) Omalizumab Effectively Prevents Recurrent Refractory Anaphylaxis in a Patient with Monoclonal Mast Cell Activation Syndrome. Annals of Allergy , Asthma & Immunology , 113, 115-116. https://doi.org/10.1016/j.anai.2014.05.001
Brigger, D., Guntern, P., Pennington, L.F., van Brummelen, R., Jardetzky, T.S. and Eggel, A. (2025) High-Affinity Omalizumab Variants with Optimized Disruptive Potency Prevent Anaphylaxis in Vivo . Journal of Allergy and Clinical Immunology , 156, 1290-1302. https://doi.org/10.1016/j.jaci.2025.05.028
Akin, C. (2025) Omalizumab for Mast Cell Disorders. Journal of Allergy and Clinical Immunology , 155, 81-83. https://doi.org/10.1016/j.jaci.2024.11.004
Malfait, F. and De Paepe, A. (2014) The Ehlers-Danlos Syndrome. In: Halper, J., Ed., Progress in Heritable Soft Connective Tissue Diseases , Springer, 129-143. https://doi.org/10.1007/978-94-007-7893-1_9
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., et al. (2017) The 2017 International Classification of the Ehlers-Danlos Syndromes. American Journal of Medical Genetics Part C : Seminars in Medical Genetics , 175, 8-26.
Spencer, M. (2024) Marfan Syndrome. Nursing , 54, 19-25. https://doi.org/10.1097/01.nurse.0001007604.09204.9a
Jiang, Y., Jia, P., Feng, X. and Zhang, D. (2025) Marfan Syndrome: Insights from Animal Models. Frontiers in Genetics , 15, Article ID: 463318. https://doi.org/10.3389/fgene.2024.1463318
Van Laer, L., Dietz, H. and Loeys, B. (2014) Loeys-Dietz Syndrome. In: Halper, J., Ed., Progress in Heritable Soft Connective Tissue Diseases , Springer, 95-105. https://doi.org/10.1007/978-94-007-7893-1_7
Hart, D.A. (2025) Regulation of Joint Tissues and Joint Function: Is There Potential for Lessons to Be Learned Regarding Regulatory Control from Joint Hypermobility Syndromes? International Journal of Molecular Sciences , 26, Article No. 1256. https://doi.org/10.3390/ijms26031256
Junkiert-Czarnecka, A., Pilarska-Deltow, M., Bąk, A., Heise, M. and Haus, O. (2023) A Novel Mutation in Collagen Transport Protein, MIA3 Gene, Detected in a Patient with Clinical Symptoms of Ehlers-Danlos Hypermobile Syndrome. Advances in Clinical and Experimental Medicine , 32, 777-781. https://doi.org/10.17219/acem/158028
Atiakshin, D., Nikolaeva, E., Gritsevskaya, D., Semyachkina, A., Kostin, A., Volodkin, A., et al. (2024) Skin Mast Cells in Marfan Syndrome: Specific Emphasis on Connective Tissue Remodeling. Archives of Dermatological Research , 316, Article No. 271. https://doi.org/10.1007/s00403-024-03033-w
Atiakshin, D., Nikolaeva, E., Semyachkina, A., Kostin, A., Volodkin, A., Morozov, S., et al. (2024) The Contribution of Mast Cells to the Regulation of Elastic Fiber Tensometry in the Skin Dermis of Children with Marfan Syndrome. International Journal of Molecular Sciences , 25, Article No. 9191. https://doi.org/10.3390/ijms25179191
Monaco, A., Choi, D., Uzun, S., Maitland, A. and Riley, B. (2022) Association of Mast-Cell-Related Conditions with Hypermobile Syndromes: A Review of the Literature. Immunologic Research , 70, 419-431. https://doi.org/10.1007/s12026-022-09280-1
Hamilton, M.J., Hornick, J.L., Akin, C., Castells, M.C. and Greenberger, N.J. (2011) Mast Cell Activation Syndrome: A Newly Recognized Disorder with Systemic Clinical Manifestations. Journal of Allergy and Clinical Immunology , 128, 147-152.e2. https://doi.org/10.1016/j.jaci.2011.04.037
Afrin, L.B. (2021) Some Cases of Hypermobile Ehlers-Danlos Syndrome May Be Rooted in Mast Cell Activation Syndrome. American Journal of Medical Genetics Part C : Seminars in Medical Genetics , 187, 466-472. https://doi.org/10.1002/ajmg.c.31944
Hamilton, M.J. (2023) Addressing Controversies in Mast Cell Activation Syndrome: Analysis Using the Cluster Instrument. Digestive Diseases and Sciences , 68, 3208-3210. https://doi.org/10.1007/s10620-023-07923-3
Castells, M., Giannetti, M.P., Hamilton, M.J., Novak, P., Pozdnyakova, O., Nicoloro-SantaBarbara, J., et al. (2024) Mast Cell Activation Syndrome: Current Understanding and Research Needs. Journal of Allergy and Clinical Immunology , 154, 255-263. https://doi.org/10.1016/j.jaci.2024.05.025
Igharo, D., Thiel, J.C., Rolke, R., Akkaya, M., Weis, J., Katona, I., et al. (2023) Skin Biopsy Reveals Generalized Small Fibre Neuropathy in Hypermobile Ehlers-Danlos Syndromes. European Journal of Neurology , 30, 719-728. https://doi.org/10.1111/ene.15649
Columbo, M., Bochner, B.S. and Marone, G. (1995) Human Mast Cells Adhere to Extracellular Matrix Proteins through Their Selective Expression of β 1 Integrins. International Archives of Allergy and Immunology , 107, 336-337. https://doi.org/10.1159/000237020
Columbo, M., Bochner, B.S. and Marone, G. (1995) Human Skin Mast Cells Express Functional beta 1 Integrins That Mediate Adhesion to Extracellular Matrix Proteins. The Journal of Immunology , 154, 6058-6064. https://doi.org/10.4049/jimmunol.154.11.6058
Suber, J. and Iweala, O.I. (2020) Strategies for Mast Cell Inhibition in Food Allergy. Yale Journal of Biology and Medicine , 93, 719-731.
Yu, M., Song, X., Liu, B., Luan, T., Liao, S. and Zhao, Z. (2021) The Emerging Role of Mast Cells in Response to Fungal Infection. Frontiers in Immunology , 12, Article ID: 688659. https://doi.org/10.3389/fimmu.2021.688659
Cazzato, D., Castori, M., Lombardi, R., Caravello, F., Bella, E.D., Petrucci, A., et al. (2016) Small Fiber Neuropathy Is a Common Feature of Ehlers-Danlos Syndromes. Neurology , 87, 155-159. https://doi.org/10.1212/wnl.0000000000002847
Novak, P., Giannetti, M.P., Weller, E., Hamilton, M.J. and Castells, M. (2022) Mast Cell Disorders Are Associated with Decreased Cerebral Blood Flow and Small Fiber Neuropathy. Annals of Allergy , Asthma & Immunology , 128, 299-306.e1. https://doi.org/10.1016/j.anai.2021.10.006
Fairweather, D., Bruno, K.A., Darakjian, A.A., Bruce, B.K., Gehin, J.M., Kotha, A., et al. (2023) High Overlap in Patients Diagnosed with Hypermobile Ehlers-Danlos Syndrome or Hypermobile Spectrum Disorders with Fibromyalgia and 40 Self-Reported Symptoms and Comorbidities. Frontiers in Medicine , 10, Article ID: 1096180. https://doi.org/10.3389/fmed.2023.1096180
Alsiri, N., Alhadhoud, M., Alkatefi, T. and Palmer, S. (2023) The Concomitant Diagnosis of Fibromyalgia and Connective Tissue Disorders: A Systematic Review. Seminars in Arthritis and Rheumatism , 58, Article ID: 152127. https://doi.org/10.1016/j.semarthrit.2022.152127
Rowe, P.C., Barron, D.F., Calkins, H., Maumenee, I.H., Tong, P.Y. and Geraghty, M.T. (1999) Orthostatic Intolerance and Chronic Fatigue Syndrome Associated with Ehlers-Danlos Syndrome. The Journal of Pediatrics , 135, 494-499. https://doi.org/10.1016/s0022-3476(99)70173-3
Castori, M., Celletti, C., Camerota, F. and Grammatico, P. (2011) Chronic Fatigue Syndrome Is Commonly Diagnosed in Patients with Ehlers-Danlos Syndrome Hypermobility Type/Joint Hypermobility Syndrome. Clinical and Experimental Rheumatology , 29, 597-598.
Hakim, A., De Wandele, I., O’Callaghan, C., Pocinki, A. and Rowe, P. (2017) Chronic Fatigue in Ehlers-Danlos Syndrome—Hypermobile Type. American Journal of Medical Genetics Part C : Seminars in Medical Genetics , 175, 175-180. https://doi.org/10.1002/ajmg.c.31542
Collins Hutchinson, M.L., Liang, E., Fuster, E. and Blitshteyn, S. (2025) Autonomic Symptom Burden, Comorbidities and Quality of Life in Women with Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome. Autonomic Neuroscience , 262, Article ID: 103356. https://doi.org/10.1016/j.autneu.2025.103356